Skip to content

Exploratory study on the safety, feasibility, and necessity of blood flow restriction training for malignant tumor patients

Exploratory study on the safety, feasibility, and necessity of blood flow restriction training for malignant tumor patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094456
Enrollment
Unknown
Registered
2024-12-23
Start date
2024-05-06
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignancy

Interventions

aerobic exercise:The same subject was randomly assigned to perform three types of exercise: 10 minutes of pure aerobic exercise on a bicycle, 100 mmHg blood flow restriction combined with 10 minutes o
resistance exercise:The same subject was randomly assigned to perform three types of exercises: resistance exercise alone, flow restriction combined with resistance exercise at a pressure level of 100

Sponsors

Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Age >= 18 years old; (2) Malignant tumors that meet the relevant diagnostic criteria for malignant tumors and have been diagnosed through imaging, pathology, or cytological examination; (3) Karnofsky (Karnofsky, KPS, percentage method) score >= 60 points; (4) No cognitive impairment, clear consciousness, able to communicate normally; (5) The patient is willing and able to complete the relevant questions in the survey questionnaire and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with contraindications to exercise, such as severe skeletal muscle disorders and serious diseases such as heart, lung, liver, and kidney; Have a history of spinal nerve injury or injury; Severe asthma, severe osteoporosis, etc; (2) Tumor related symptoms are obvious and potentially threatening survivors; (3) Malignant tumors with brain or bone metastasis, thrombocytopenia (<50 × 10^9), myocardial infarction or uncontrolled hypertension within the past three months; (4) Ultrasound shows deep vein thrombosis in the lower limbs, bone and joint surgery within 6 months, and vascular or skin transplantation in the lower limbs for 6 months; (5) Use of anticoagulants, systemic open soft tissue injury, and systemic lymphedema; (6) Individuals with perceptual impairments.

Design outcomes

Primary

MeasureTime frame
blood pressure;heart rate;Blood oxygen saturation;Muscle oxygen;Surface electromyography;

Secondary

MeasureTime frame
Discomfort rating;Perceived stress rating;Pain score;rating of perceived exertion;

Countries

China

Contacts

Public ContactLi Wang

Soochow University

li-wang-1@suda.edu.cn+86 158 6237 6628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026